Neta Barashi
Hebrew University of Jerusalem
7 Papers
72 Citations
Neta Barashi is an academic researcher from Hebrew University of Jerusalem. The author has contributed to research in topics: Chemokine receptor & CCR1. The author has an hindex of 4, co-authored 5 publications.
Chat about Author
Papers
Inflammation-induced hepatocellular carcinoma is dependent on CCR5 in mice.
Neta Barashi,Ido D. Weiss,Ori Wald,Hanna Wald,Katia Beider,Michal Abraham,Shiri Klein,Daniel Goldenberg,Jonathan H. Axelrod,Eli Pikarsky,Rinat Abramovitch,Evelyne Zeira,Eithan Galun,Amnon Peled +13 more
TL;DR: The results indicate that CCR5 has a critical role in both the development and progression of liver cancer, and it is proposed that a C CR5 antagonist can serve for HCC cancer prevention and treatment.
76
Interstrain differences in chronic hepatitis and tumor development in a murine model of inflammation‐mediated hepatocarcinogenesis
Tamara Potikha,Evgeniy Stoyanov,Orit Pappo,Antonina Frolov,Antonina Frolov,Lina Mizrahi,Deborah Olam,Temima Shnitzer-Perlman,Ido D. Weiss,Neta Barashi,Amnon Peled,Gabriele Sass,Gisa Tiegs,Françoise Poirier,Gabriel A. Rabinovich,Gabriel A. Rabinovich,Eithan Galun,Daniel Goldenberg +17 more
TL;DR: Decreased chronic hepatitis in Mdr2‐KO/B6 mice at the age of 3 months correlated with a significant retardation of liver tumor development in this strain versus the Mdr1‐ KO/FVB strain.
43
Ccr5 deficiency regulates the proliferation and trafficking of natural killer cells under physiological conditions.
Ido D. Weiss,Hadas Shoham,Ori Wald,Hanna Wald,Katia Beider,Michal Abraham,Neta Barashi,Eithan Galun,Arnon Nagler,Amnon Peled +9 more
TL;DR: Under physiological conditions, the bone marrow, spleen, blood and liver of Ccr5, but not of CCr1-deficient mice, contain reduced numbers of NK cells, suggesting a role for CCr5 in NK cell proliferation and circulation under physiological conditions and a complex role in determining the fate ofNK cells under pathological conditions.
30
CCL24 regulates biliary inflammation and fibrosis in primary sclerosing cholangitis.
Raanan Greenman,Michal Segal-Salto,Neta Barashi,Ophir Hay,Avi Katav,O Levi,Ilan Vaknin,Revital Aricha,Tom Snir,Inbal Mishalian,Devorah Olam,Johnny Amer,A. Salhab,Rifaat Safadi,Yaakov Maor,Palak J. Trivedi,Christopher J. Easton,Francesca Saffioti,Andrew Hall,Massimo Pinzani,Douglas Thorburn,Amnon Peled,Adi Mor +22 more
TL;DR: In this paper , the role of CCL24 in primary sclerosing cholangitis (PSC) and evaluated the potential therapeutic effect of blocking CCL 24 in this disease.
Patent
Treatment and prevention of hepatocellular carcinoma with chemokine receptor modulators
Amnon Peled,Eithan Galun,Neta Barashi +2 more
- 11 Oct 2011
TL;DR: In this article, a means for specifically elevating the level of the CCR5 and CCR1 ligand RANTES in the blood of subjects afflicted with, or predisposed to developing HCC was presented.